Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -246,290 | -190,361 | -170,033 | -43,476 | -116,484 |
| Depreciation Amortization | 2,188 | 1,369 | 880 | 443 | 1,646 |
| Accounts receivable | N/A | N/A | N/A | -1 | N/A |
| Accounts payable and accrued liabilities | 1,921 | 2,198 | 3,468 | 5,282 | N/A |
| Other Working Capital | 12,362 | 2,463 | 4,680 | 6,953 | -7,883 |
| Other Operating Activity | 61,090 | 67,296 | 88,256 | -1,303 | 1,140 |
| Operating Cash Flow | $-168,729 | $-117,035 | $-72,749 | $-32,102 | $-121,581 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -801 | -627 | -226 | -101 | -358 |
| Purchase Sale Intangibles | -2,008 | -1,408 | -408 | -375 | N/A |
| Other Investing Activity | -2,027 | -1,408 | -408 | -395 | -1,890 |
| Investing Cash Flow | $-2,828 | $-2,035 | $-634 | $-496 | $-2,248 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 62,898 | 62,898 | 62,896 | N/A | N/A |
| Common Stock Issued | 433,212 | 435,868 | 244,213 | N/A | N/A |
| Other Financing Activity | -1,144 | -929 | -554 | -278 | 100,512 |
| Financing Cash Flow | $494,966 | $497,837 | $306,555 | $-278 | $100,512 |
| Exchange Rate Effect | 235 | 98 | -130 | -100 | 61 |
| Beginning Cash Position | 115,551 | 115,551 | 115,551 | 115,551 | 138,807 |
| End Cash Position | 439,195 | 494,416 | 348,593 | 82,575 | 115,551 |
| Net Cash Flow | $323,644 | $378,865 | $233,042 | $-32,976 | $-23,256 |
| Free Cash Flow | |||||
| Operating Cash Flow | -168,729 | -117,035 | -72,749 | -32,102 | -121,581 |
| Capital Expenditure | -801 | -627 | -226 | -101 | N/A |
| Free Cash Flow | -169,530 | -117,662 | -72,975 | -32,203 | -121,581 |